245 related articles for article (PubMed ID: 32694112)
1. [The mechanism underlying histone deacetylases regulating cardiac hypertrophy].
Ren L; Wu XS; Li YQ
Yi Chuan; 2020 Jun; 42(6):536-547. PubMed ID: 32694112
[TBL] [Abstract][Full Text] [Related]
2. Roles and targets of class I and IIa histone deacetylases in cardiac hypertrophy.
Kee HJ; Kook H
J Biomed Biotechnol; 2011; 2011():928326. PubMed ID: 21151616
[TBL] [Abstract][Full Text] [Related]
3. Regulation of acetylation of histone deacetylase 2 by p300/CBP-associated factor/histone deacetylase 5 in the development of cardiac hypertrophy.
Eom GH; Nam YS; Oh JG; Choe N; Min HK; Yoo EK; Kang G; Nguyen VH; Min JJ; Kim JK; Lee IK; Bassel-Duby R; Olson EN; Park WJ; Kook H
Circ Res; 2014 Mar; 114(7):1133-43. PubMed ID: 24526703
[TBL] [Abstract][Full Text] [Related]
4. Chromatin modifications remodel cardiac gene expression.
Mathiyalagan P; Keating ST; Du XJ; El-Osta A
Cardiovasc Res; 2014 Jul; 103(1):7-16. PubMed ID: 24812277
[TBL] [Abstract][Full Text] [Related]
5. HDAC inhibition attenuates cardiac hypertrophy by acetylation and deacetylation of target genes.
Ooi JY; Tuano NK; Rafehi H; Gao XM; Ziemann M; Du XJ; El-Osta A
Epigenetics; 2015; 10(5):418-30. PubMed ID: 25941940
[TBL] [Abstract][Full Text] [Related]
6. Roles and post-translational regulation of cardiac class IIa histone deacetylase isoforms.
Weeks KL; Avkiran M
J Physiol; 2015 Apr; 593(8):1785-97. PubMed ID: 25362149
[TBL] [Abstract][Full Text] [Related]
7. HATs off to Hop: recruitment of a class I histone deacetylase incriminates a novel transcriptional pathway that opposes cardiac hypertrophy.
Hamamori Y; Schneider MD
J Clin Invest; 2003 Sep; 112(6):824-6. PubMed ID: 12975465
[TBL] [Abstract][Full Text] [Related]
8. The role of post-translational modifications in cardiac hypertrophy.
Yan K; Wang K; Li P
J Cell Mol Med; 2019 Jun; 23(6):3795-3807. PubMed ID: 30950211
[TBL] [Abstract][Full Text] [Related]
9. Emodin and emodin-rich rhubarb inhibits histone deacetylase (HDAC) activity and cardiac myocyte hypertrophy.
Evans LW; Bender A; Burnett L; Godoy L; Shen Y; Staten D; Zhou T; Angermann JE; Ferguson BS
J Nutr Biochem; 2020 May; 79():108339. PubMed ID: 32007664
[TBL] [Abstract][Full Text] [Related]
10. Heart failure: the pivotal role of histone deacetylases.
Hewitson R; Dargan J; Collis D; Green A; Moorjani N; Ohri S; Townsend PA
Int J Biochem Cell Biol; 2013 Feb; 45(2):448-53. PubMed ID: 23178536
[TBL] [Abstract][Full Text] [Related]
11. Acetylation of proteins as novel target for antitumor therapy: review article.
Di Gennaro E; Bruzzese F; Caraglia M; Abruzzese A; Budillon A
Amino Acids; 2004 Jul; 26(4):435-41. PubMed ID: 15290351
[TBL] [Abstract][Full Text] [Related]
12. Roles of Histone Acetyltransferases and Deacetylases in the Retinal Development and Diseases.
Wang J; Feng S; Zhang Q; Qin H; Xu C; Fu X; Yan L; Zhao Y; Yao K
Mol Neurobiol; 2023 Apr; 60(4):2330-2354. PubMed ID: 36637745
[TBL] [Abstract][Full Text] [Related]
13. The role of redox modulation of class II histone deacetylases in mediating pathological cardiac hypertrophy.
Oka S; Ago T; Kitazono T; Zablocki D; Sadoshima J
J Mol Med (Berl); 2009 Aug; 87(8):785-91. PubMed ID: 19424677
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase inhibition attenuates cardiac hypertrophy and fibrosis through acetylation of mineralocorticoid receptor in spontaneously hypertensive rats.
Kang SH; Seok YM; Song MJ; Lee HA; Kurz T; Kim I
Mol Pharmacol; 2015 May; 87(5):782-91. PubMed ID: 25667225
[TBL] [Abstract][Full Text] [Related]
15. HDACs and HDAC Inhibitors in Cancer Development and Therapy.
Li Y; Seto E
Cold Spring Harb Perspect Med; 2016 Oct; 6(10):. PubMed ID: 27599530
[TBL] [Abstract][Full Text] [Related]
16. Using Histone Deacetylase Inhibitors to Analyze the Relevance of HDACs for Translation.
Hutt DM; Roth DM; Marchal C; Bouchecareilh M
Methods Mol Biol; 2017; 1510():77-91. PubMed ID: 27761814
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of histone acetylation and deacetylation enzymes affects longevity, development, and fecundity in the pea aphid (Acyrthosiphon pisum).
Kirfel P; Skaljac M; Grotmann J; Kessel T; Seip M; Michaelis K; Vilcinskas A
Arch Insect Biochem Physiol; 2020 Mar; 103(3):e21614. PubMed ID: 31498475
[TBL] [Abstract][Full Text] [Related]
18. Non-sirtuin histone deacetylases in the control of cardiac aging.
Ferguson BS; McKinsey TA
J Mol Cell Cardiol; 2015 Jun; 83():14-20. PubMed ID: 25791169
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylases in cardiac fibrosis: current perspectives for therapy.
Tao H; Shi KH; Yang JJ; Huang C; Zhan HY; Li J
Cell Signal; 2014 Mar; 26(3):521-7. PubMed ID: 24321371
[TBL] [Abstract][Full Text] [Related]
20. Targeting cardiac fibroblasts to treat fibrosis of the heart: focus on HDACs.
Schuetze KB; McKinsey TA; Long CS
J Mol Cell Cardiol; 2014 May; 70():100-7. PubMed ID: 24631770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
